Business Description
Sagittarius Life Science Corp
NAICS : 325412
SIC : 2834
ISIN : TW0003205001
Description
Sagittarius Life Science Corp is a Taiwan based company engaged in operating as a biotechnology and pharmaceutical company. Its business activity is to develop Chinese herbal medicines and supplements for the treatment of bone fractures, osteoporosis, wound healing and skin care.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.53 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 6.87 | |||||
| Beneish M-Score | -2.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.5 | |||||
| 3-Year EBITDA Growth Rate | 4.2 | |||||
| 3-Year EPS without NRI Growth Rate | 9.4 | |||||
| 3-Year FCF Growth Rate | 0.9 | |||||
| 3-Year Book Growth Rate | -4.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.32 | |||||
| 9-Day RSI | 28.02 | |||||
| 14-Day RSI | 31.72 | |||||
| 3-1 Month Momentum % | -4.35 | |||||
| 6-1 Month Momentum % | -12.33 | |||||
| 12-1 Month Momentum % | -23.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.67 | |||||
| Quick Ratio | 2.35 | |||||
| Cash Ratio | 1.75 | |||||
| Days Inventory | 30.47 | |||||
| Days Sales Outstanding | 31.15 | |||||
| Days Payable | 62.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.46 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.06 | |||||
| Operating Margin % | -16.05 | |||||
| Net Margin % | -12.96 | |||||
| FCF Margin % | -12.57 | |||||
| ROE % | -12.03 | |||||
| ROA % | -9.49 | |||||
| ROIC % | -21.69 | |||||
| 3-Year ROIIC % | 6.87 | |||||
| ROC (Joel Greenblatt) % | -54.82 | |||||
| ROCE % | -11.93 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 172.45 | |||||
| PS Ratio | 2.48 | |||||
| PB Ratio | 2.44 | |||||
| Price-to-Tangible-Book | 2.38 | |||||
| EV-to-EBIT | -15.33 | |||||
| EV-to-EBITDA | -20.44 | |||||
| EV-to-Revenue | 2.06 | |||||
| EV-to-FCF | -16.7 | |||||
| Price-to-GF-Value | 0.87 | |||||
| Price-to-Median-PS-Value | 0.8 | |||||
| Price-to-Net-Current-Asset-Value | 7.64 | |||||
| Price-to-Net-Cash | 20.55 | |||||
| Earnings Yield (Greenblatt) % | -6.52 | |||||
| FCF Yield % | -5.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sagittarius Life Science Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 455.336 | ||
| EPS (TTM) (NT$) | -1.81 | ||
| Beta | 0.26 | ||
| 3-Year Sharpe Ratio | 0.38 | ||
| 3-Year Sortino Ratio | 0.82 | ||
| Volatility % | 33.2 | ||
| 14-Day RSI | 31.72 | ||
| 14-Day ATR (NT$) | 1.01784 | ||
| 20-Day SMA (NT$) | 34.3425 | ||
| 12-1 Month Momentum % | -23.23 | ||
| 52-Week Range (NT$) | 32.85 - 52.9 | ||
| Shares Outstanding (Mil) | 32.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sagittarius Life Science Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sagittarius Life Science Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sagittarius Life Science Corp Frequently Asked Questions
What is Sagittarius Life Science Corp(ROCO:3205)'s stock price today?
The current price of ROCO:3205 is NT$33.70. The 52 week high of ROCO:3205 is NT$52.90 and 52 week low is NT$32.85.
When is next earnings date of Sagittarius Life Science Corp(ROCO:3205)?
The next earnings date of Sagittarius Life Science Corp(ROCO:3205) is .
Does Sagittarius Life Science Corp(ROCO:3205) pay dividends? If so, how much?
Sagittarius Life Science Corp(ROCO:3205) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers